Evidence map›Paper›PMID 23223629›Full record

ReviewPhysiology (Bethesda, Md.)2012

Nonequilibrium gating of CFTR on an equilibrium theme.

Kang-Yang Jih, Tzyh-Chang Hwang

Open access · greenAbstract readReview
In one paragraph

Review in Physiology (Bethesda, Md.), 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 23 papers.

0numbers the graph read from it
0cells of the map it votes in
23citing papers in PubMed
3.9field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

23 citing papers in PubMed, 40 citations in OpenAlex.

  1. CFTR Modulators: From Mechanism to Targeted Therapeutics.Handbook of experimental pharmacology · 2024
    Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Structural mechanisms of CFTR function and dysfunction.The Journal of general physiology · 2018
    Review
  7. Article
  8. CFTR potentiators: from bench to bedside.Current opinion in pharmacology · 2017
    Review
  9. Article
  10. Architecture and functional properties of the CFTR channel pore.Cellular and molecular life sciences : CMLS · 2017
    Review
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Localizing a gate in CFTR.Proceedings of the National Academy of Sciences of the United States of America · 2015
    Article
  18. Modulation of CFTR gating by permeant ions.The Journal of general physiology · 2015
    Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 1 institution in 1 country.

Kang-Yang JihDalton Cardiovascular Research Center, University of Missouri-Columbia, Columbia, Missouri, USA.
Tzyh-Chang Hwang
University of Missouri · US

Funding

MOLECULAR PATHOPHYSIOLOGY OF CYSTIC FIBROSISR01DK055835 · NIDDK · UNIVERSITY OF MISSOURI-COLUMBIA · PI HWANG, TZYH-CHANG · 1999 to 2022
$6.1M
GATING OF CFTR CL CHANNELS BY ATP HYDROLYSISR01HL053445 · NHLBI · UNIVERSITY OF MISSOURI-COLUMBIA · PI HWANG, TZYH-CHANG · 2001 to 2009
$2.3M
NHLBI NIH HHS R01 HL053445NIDDK NIH HHS R01 DK055835NIDDK NIH HHS R01 DK-55835
6 · The paper itself

Abstract

Malfunction of cystic fibrosis transmembrane conductance regulator (CFTR), a member of the ABC protein superfamily that functions as an ATP-gated chloride channel, causes the lethal genetic disease, cystic fibrosis. This review focuses on the most recent findings on the gating mechanism of CFTR. Potential clinical relevance and implications to ABC transporter function are also discussed.

Indexed as

ATP-Binding Cassette TransportersChloride ChannelsCystic FibrosisCystic Fibrosis Transmembrane Conductance RegulatorIon Channel GatingATP-Binding Cassette TransportersChloride ChannelsCystic Fibrosis Transmembrane Conductance Regulator

Identifiers

PMID23223629
PMCPMC4931552
OpenAlexW2170377964

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.